Yahoo
Shanghai - Delayed Quote CNY

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (688796.SS)

77.35 -5.22 (-6.32%)
At close: October 30 at 3:00:01 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,699,234
1,378,808
980,454
716,912
533,881
Cost of Revenue
369,103
333,218
218,935
210,878
142,131
Gross Profit
1,330,131
1,045,590
761,519
506,034
391,750
Operating Expense
839,058
766,991
611,314
807,223
993,828
Operating Income
491,073
278,599
150,205
-301,189
-602,078
Net Non Operating Interest Income Expense
-66,579
-66,730
-85,780
-89,686
-53,972
Pretax Income
376,979
188,030
42,940
-380,156
-601,353
Tax Provision
10,685
14,831
9,403
2,796
804
Net Income Common Stockholders
366,295
173,199
33,542
-382,951
-601,945
Diluted NI Available to Com Stockholders
366,295
173,199
33,542
-382,951
-601,945
Basic EPS
0.85
0.43
0.08
-0.96
-1.58
Diluted EPS
0.85
0.43
0.08
-0.96
-1.58
Basic Average Shares
423,696.50
400,076
398,011
398,314
381,004
Diluted Average Shares
423,696.50
400,076
398,011
398,314
381,004
Total Operating Income as Reported
479,018
281,337
164,368
-270,285
-530,444
Total Expenses
1,208,161
1,100,209
830,249
1,018,101
1,135,959
Net Income from Continuing & Discontinued Operation
366,295
173,199
33,542
-382,951
-601,945
Normalized Income
364,891.93
170,439.31
33,816.92
-384,436.75
-633,595
Interest Income
4,509
4,271
5,895
10,158
2,167
Interest Expense
71,088
71,001
91,675
99,844
56,139
Net Interest Income
-66,579
-66,730
-85,780
-89,686
-53,972
EBIT
448,067
259,031
134,615
-280,312
-545,214
EBITDA
448,067
419,489
303,796
-97,867
-371,115
Reconciled Cost of Revenue
369,103
333,218
218,935
210,878
142,131
Reconciled Depreciation
--
160,458
169,181
182,445
174,099
Net Income from Continuing Operation Net Minority Interest
366,295
173,199
33,542
-382,951
-601,945
Total Unusual Items Excluding Goodwill
1,444
2,996
-352
1,981
42,200
Total Unusual Items
1,444
2,996
-352
1,981
42,200
Normalized EBITDA
446,623
416,493
304,148
-99,848
-413,315
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
40.93
236.31
-77.08
495.25
10,550
12/31/2022 - 12/10/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: